AT
Allogene Therapeutics Inc
🇺🇸XNAS.ALLOUnited StatesHealthcare
$1.73USDunchanged 0.00 (0%)OpenDelayed2:26 PM
Price$1.730.00 (0%)
Profile
- Healthcare
- Biotechnology
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US0197701065
- CUSIP
- 019770106
Company
- Employees
- 150
- Headquarters
- South San Francisco, United States
- Website
- https://allogene.com
- CEO
- Dr. Zachary J. Roberts M.D., Ph.D.
Market
- Shares outstanding
- 345.5M
- Market cap
- $597.7M
Key dates
- Next earnings
- Nov 5, 2026
Highlights
- Market cap
- $594.24M
- EPS LTM
- -$0.50
- P/E LTM
- -4.35
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $4.64M+21,190.91%up year on year
- Net income
- -$165.49M+30.14%up year on year
- Gross margin
- -699.35%-100.17%down year on year
- Free cash flow
- -$102.6M+40.9%up year on year
Other listings
This company is not listed on any other exchange we cover.
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.